Header Logo

Francesco Massari MD, PhD

TitleAssociate Professor
InstitutionUMass Chan Medical School
DepartmentRadiology
AddressUniversity of Massachusetts Medical School
55 Lake Ave North
Worcester MA 01605
vCardDownload vCard
    Other Positions
    InstitutionT.H. Chan School of Medicine
    DepartmentRadiology


    Collapse Biography 
    Collapse education and training
    Sapienza University of Rome, Rome, RM, ItalyMSRadiology
    Sapienza University of Rome, Rome, RM, ItalyMD
    Sapienza University of Rome, Rome, RM, ItalyPHDRadiology
    Medical University of South Carolina, Charleston, South CarolinaFellowship
    University of Massachusetts Medical School, Worcester, MAFellowship

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Akamatsu Y, Gomez-Paz S, Tonetti DA, Vergara-Garcia D, Moholkar VM, Kuhn AL, Chida K, Singh J, Rodrigues KM, Massari F, Moore JM, Ogilvy CS, Puri AS, Thomas AJ. Middle meningeal artery: An effective pathway for achieving complete obliteration following transarterial Ethylene Vinyl Copolymer (Onyx) embolization of dural arteriovenous fistulas. J Cerebrovasc Endovasc Neurosurg. 2022 Jul 07. PMID: 35794751.
      Citations:    
    2. Santoni M, Massari F, Matrana MR, Basso U, De Giorgi U, Aurilio G, Buti S, Incorvaia L, Rizzo M, Martignetti A, Maslov D, Tawagi K, Philon E, Blake Z, Porta C, Battelli N. Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma. Eur J Cancer. 2022 Jun 30; 172:191-198. PMID: 35780525.
      Citations:    Fields:    
    3. Massari F, Dabus G, Cortez GM, Singh J, Kuhn AL, Naragum V, Anagnostakou V, Hanel RA, Gounis MJ, Puri AS. Super large-bore ingestion of clot (SLIC) leads to high first pass effect in thrombectomy for large vessel occlusion. J Neurointerv Surg. 2022 Jun 22. PMID: 35732483.
      Citations:    Fields:    
    4. Rizzo A, Mollica V, Santoni M, Massari F. Clinicopathological Features of FGFR3 - Mutated Upper Tract Urothelial Carcinoma: A Genomic Database Analysis. Clin Genitourin Cancer. 2022 Jun 18. PMID: 35858936.
      Citations:    Fields:    
    5. Santoni M, Monteiro FSM, Massari F, Abahssain H, Aurilio G, Molina-Cerrillo J, Myint ZW, Zabalza IO, Battelli N, Grande E. Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survival. Crit Rev Oncol Hematol. 2022 Aug; 176:103731. PMID: 35718065.
      Citations:    Fields:    Translation:Humans
    6. Santoni M, Massari F, Rizzo A, Mollica V, Cimadamore A, Montironi R, Battelli N. Apalutamide or enzalutamide in castration-sensitive prostate cancer: a number needed to treat analysis. Tumori. 2022 May 20; 3008916221090323. PMID: 35593453.
      Citations:    Fields:    
    7. Rizzo A, Santoni M, Mollica V, Ricci AD, Calabrò C, Cusmai A, Gadaleta-Caldarola G, Palmiotti G, Massari F. The Impact of Concomitant Proton Pump Inhibitors on Immunotherapy Efficacy among Patients with Urothelial Carcinoma: A Meta-Analysis. J Pers Med. 2022 May 20; 12(5). PMID: 35629263.
      Citations:    
    8. Rizzo A, Mollica V, Merler S, Morelli F, Sorgentoni G, Oderda M, Santoni M, Massari F. Incidence of grade 3-4 adverse events, dose reduction, and treatment discontinuation in castration-resistant prostate cancer patients receiving PARP inhibitors: a meta-analysis. Expert Opin Drug Metab Toxicol. 2022 Mar; 18(3):235-240. PMID: 35485878.
      Citations:    Fields:    Translation:Humans
    9. Singh J, Kuhn AL, Massari F, Elnazeir M, Kutcher R, Puri AS. Intravascular lithotripsy for severely calcified carotid artery stenosis - A new frontier in carotid artery stenting? Interv Neuroradiol. 2022 May 03; 15910199221097887. PMID: 35505603.
      Citations:    Fields:    
    10. Srinivasan VM, Dmytriw AA, Regenhardt RW, Vicenty-Padilla J, Alotaibi NM, Levy E, Waqas M, Cherian J, Johnson JN, Jabbour P, Sweid A, Gross B, Starke RM, Puri A, Massari F, Griessenauer CJ, Catapano JS, Rutledge C, Tanweer O, Yashar P, Cortez GM, Aziz-Sultan MA, Patel AB, Ducruet AF, Albuquerque FC, Hanel RA, Lawton MT, Kan P. Retreatment of Residual and Recurrent Aneurysms After Embolization With the Woven EndoBridge Device: Multicenter Case Series. Neurosurgery. 2022 05 01; 90(5):569-580. PMID: 35244028.
      Citations:    Fields:    Translation:Humans
    11. Rizzo A, Mollica V, Santoni M, Massari F. Assessing PD-L1 status in mRCC treated with first-line immune-based combinations: a meta-analysis. Immunotherapy. 2022 06; 14(8):617-625. PMID: 35416060.
      Citations:    Fields:    Translation:Humans
    12. Santoni M, Molina-Cerrillo J, Massari F, Montironi R, Grande E. Re: Effect of Immunotherapy Time-of-day Infusion on Overall Survival Among Patients with Advanced Melanoma in the USA (MEMOIR): A Propensity Score-matched Analysis of a Single-centre, Longitudinal Study. Eur Urol. 2022 Jun; 81(6):623-624. PMID: 35367085.
      Citations:    Fields:    Translation:Humans
    13. Rebuzzi SE, Cerbone L, Signori A, Santoni M, Murianni V, De Giorgi U, Procopio G, Porta C, Milella M, Basso U, Massari F, Maruzzo M, Iacovelli R, Battelli N, Carmisciano L, Banna GL, Buti S, Fornarini G. Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib. Ther Adv Med Oncol. 2022; 14:17588359221079580. PMID: 35237353.
      Citations:    
    14. Kühn AL, Singh J, Massari F, de Macedo Rodrigues K, Gounis MJ, Puri AS. Flow Diverter Reconstruction of Internal Carotid Artery (Loop) Dissections with or without Associated Pseudoaneurysms. World Neurosurg. 2022 Jun; 162:e65-e72. PMID: 35217230.
      Citations:    Fields:    Translation:Humans
    15. Santoni M, Massari F, Bracarda S, Grande E, Matrana MR, Rizzo M, De Giorgi U, Basso U, Aurilio G, Incorvaia L, Martignetti A, Molina-Cerrillo J, Mollica V, Rizzo A, Battelli N. Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase Inhibitors. Eur Urol Focus. 2022 Feb 19. PMID: 35193819.
      Citations:    Fields:    
    16. Santoni M, Aurilio G, Massari F, Grande E, Matrana MR, Rizzo M, De Giorgi U, Incorvaia L, Martignetti A, Molina-Cerrillo J, Zabalza IO, Mollica V, Rizzo A, Battelli N, Porta C. Nivolumab VERSUS Cabozantinib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma: A Real-World Comparison. Clin Genitourin Cancer. 2022 06; 20(3):285-295. PMID: 35305916.
      Citations:    Fields:    Translation:Humans
    17. Rizzo A, Mollica V, Santoni M, Palmiotti G, Massari F. Pathologic Complete Response in Urothelial Carcinoma Patients Receiving Neoadjuvant Immune Checkpoint Inhibitors: A Meta-Analysis. J Clin Med. 2022 Feb 17; 11(4). PMID: 35207311.
      Citations:    
    18. Marchetti A, Rosellini M, Nuvola G, Tassinari E, Mollica V, Rizzo A, Santoni M, Cimadamore A, Farolfi A, Montironi R, Fanti S, Massari F. PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What's Now, What's New, and What's Coming? Cancers (Basel). 2022 Feb 11; 14(4). PMID: 35205654.
      Citations:    
    19. Rizzo A, Santoni M, Mollica V, Logullo F, Rosellini M, Marchetti A, Faloppi L, Battelli N, Massari F. Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 study. Expert Opin Drug Metab Toxicol. 2021 Dec; 17(12):1455-1466. PMID: 35029519.
      Citations:    Fields:    Translation:Humans
    20. Rizzo A, Mollica V, Santoni M, Ricci AD, Gadaleta-Caldarola G, Montironi R, Massari F. Impact of clinicopathological features on immune-based combinations for advanced urothelial carcinoma: a meta-analysis. Future Oncol. 2022 Feb; 18(6):739-748. PMID: 35048736.
      Citations: 2     Fields:    Translation:Humans
    21. Santoni M, Rizzo A, Mollica V, Matrana MR, Rosellini M, Faloppi L, Marchetti A, Battelli N, Massari F. The impact of gender on The efficacy of immune checkpoint inhibitors in cancer patients: The MOUSEION-01 study. Crit Rev Oncol Hematol. 2022 Feb; 170:103596. PMID: 35031442.
      Citations:    Fields:    Translation:Humans
    22. Marino Granados J, Kuhn AL, Puri AS, Massari F, Singh J. Acutely Symptomatic Hypoperfusion Through an Occluded Subclavian to Internal Carotid Artery Bypass Graft: Salvage Mechanical Thrombectomy and Graft Revascularization. Cureus. 2022 Jan; 14(1):e20881. PMID: 35145787.
      Citations:    
    23. Locuratolo N, Scicchitano P, Antoncecchi E, Basso P, Bonfantino VM, Brescia F, Carrata F, De Martino G, Landriscina R, Lanzone S, Lillo A, Massari F, Musci S, Palumbo V, Paolillo C, Rutigliano D, Rutigliano S, Sublimi Saponetti L, Scalera G, Spadafina T, Squiccimarro E, Tota F, Caldarola P. [Follow-up of patients after an acute coronary event: the Apulia PONTE-SCA program]. G Ital Cardiol (Rome). 2022 Jan; 23(1):63-74. PMID: 34985464.
      Citations: 1     Fields:    Translation:Humans
    24. Rizzo A, Oderda M, Mollica V, Merler S, Morelli F, Fragomeno B, Taveri E, Sorgentoni G, Santoni M, Massari F. A meta-analysis on overall survival and safety outcomes in patients with nonmetastatic castration-resistant prostate cancer treated with novel hormonal agents. Anticancer Drugs. 2022 01 01; 33(1):e43-e51. PMID: 34387593.
      Citations: 1     Fields:    Translation:Humans
    25. Nigro MC, Mollica V, Marchetti A, Cheng M, Rosellini M, Montironi R, Cheng L, Massari F. Current androgen receptor antagonists under investigation for resistant prostate cancer. Expert Rev Anticancer Ther. 2022 Feb; 22(2):191-202. PMID: 34928193.
      Citations:    Fields:    Translation:Humans
    26. Rizzo A, Mollica V, Santoni M, Rosellini M, Marchetti A, Massari F. Risk of toxicity with immunotherapy-tyrosine kinase inhibitors for metastatic renal cell carcinoma: a meta-analysis of randomized controlled trials. Future Oncol. 2022 Feb; 18(5):625-634. PMID: 34927453.
      Citations:    Fields:    Translation:Humans
    27. Mollica V, Marchetti A, Rosellini M, Nuvola G, Rizzo A, Santoni M, Cimadamore A, Montironi R, Massari F. An Insight on Novel Molecular Pathways in Metastatic Prostate Cancer: A Focus on DDR, MSI and AKT. Int J Mol Sci. 2021 Dec 16; 22(24). PMID: 34948314.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    28. Mollica V, Santoni M, Matrana MR, Basso U, De Giorgi U, Rizzo A, Maruzzo M, Marchetti A, Rosellini M, Bleve S, Maslov D, Tawagi K, Philon E, Blake Z, Massari F. Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma. Target Oncol. 2022 01; 17(1):61-68. PMID: 34894318.
      Citations: 8     Fields:    Translation:Humans
    29. Rizzo A, Mollica V, Santoni M, Massari F. Cancer Immunotherapy: Current and Future Perspectives on a Therapeutic Revolution. J Clin Med. 2021 Nov 11; 10(22). PMID: 34830536.
      Citations:    
    30. Salem MM, Khorasanizadeh M, Lay SV, Renieri L, Kuhn AL, Sweid A, Massari F, Moore JM, Tjoumakaris SI, Jabbour P, Puri AS, Ogilvy CS, Jankowitz BT, Burkhardt JK, Kan P, Limbucci N, Cognard C, Thomas AJ. Endoluminal flow diverting stents for middle cerebral artery bifurcation aneurysms: multicenter cohort. J Neurointerv Surg. 2021 Nov 03. PMID: 34732531.
      Citations:    Fields:    
    31. Aurilio G, Santoni M, Massari F, Cimadamore A, Rizzo A, Mollica V, Verri E, Battelli N, Montironi R. Metabolomic Profiling in Renal Cell Carcinoma Patients: News and Views. Cancers (Basel). 2021 Oct 18; 13(20). PMID: 34680377.
      Citations:    
    32. Kuhn AL, Puri AS, Massari F, Singh J. Intravascular Wrap for Treatment of Basilar Artery Perforator Aneurysm. Cureus. 2021 Sep; 13(9):e18021. PMID: 34692271.
      Citations:    
    33. Rizzo A, Santoni M, Mollica V, Fiorentino M, Brandi G, Massari F. Microbiota and prostate cancer. Semin Cancer Biol. 2021 Sep 15. PMID: 34536504.
      Citations: 2     Fields:    
    34. Rizzo A, Merler S, Sorgentoni G, Oderda M, Mollica V, Gadaleta-Caldarola G, Santoni M, Massari F. Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: a systematic review and meta-analysis. Expert Opin Drug Metab Toxicol. 2021 Oct; 17(10):1237-1243. PMID: 34407702.
      Citations: 2     Fields:    Translation:Humans
    35. Marchetti A, Rosellini M, Rizzo A, Mollica V, Battelli N, Massari F, Santoni M. An up-to-date evaluation of cabozantinib for the treatment of renal cell carcinoma. Expert Opin Pharmacother. 2021 Dec; 22(17):2323-2336. PMID: 34405738.
      Citations: 1     Fields:    Translation:Humans
    36. Santoni M, Massari F, Grande E, Procopio G, Matrana MR, Rizzo M, De Giorgi U, Basso U, Milella M, Iacovelli R, Aurilio G, Incorvaia L, Buti S, Caffo O, Fornarini G, Carrozza F, Mollica V, Rizzo A, Farag F, Molina-Cerrillo J, Battelli N. Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study. Target Oncol. 2021 09; 16(5):625-632. PMID: 34338966.
      Citations:    Fields:    Translation:Humans
    37. Massari F, Rizzo A, Mollica V, Rosellini M, Marchetti A, Ardizzoni A, Santoni M. Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials. Eur J Cancer. 2021 09; 154:120-127. PMID: 34265504.
      Citations: 28     Fields:    Translation:Humans
    38. Mollica V, Brocchi S, Dall'Olio FG, Marcolin L, Paccapelo A, Santoni M, Rizzo A, Montironi R, Golfieri R, Massari F, Ardizzoni A. Tumor Growth Rate Decline despite Progressive Disease May Predict Improved Nivolumab Treatment Outcome in mRCC: When RECIST Is Not Enough. Cancers (Basel). 2021 Jul 12; 13(14). PMID: 34298702.
      Citations:    
    39. Cimadamore A, Mazzucchelli R, Lopez-Beltran A, Massari F, Santoni M, Scarpelli M, Cheng L, Montironi R. Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation. Cancers (Basel). 2021 Jul 11; 13(14). PMID: 34298683.
      Citations:    
    40. Rizzo A, Mollica V, Santoni M, Massari F. Risk of selected gastrointestinal toxicities in metastatic renal cell carcinoma patients treated with immuno-TKI combinations: a meta-analysis. Expert Rev Gastroenterol Hepatol. 2021 Oct; 15(10):1225-1232. PMID: 34167420.
      Citations: 3     Fields:    Translation:Humans
    41. Elnazeir M, Nobel L, Narayanan S, Darmoch F, Massari F, Fitzgibbons T, Carandang RA, Jun-O'Connell A. Left Ventricular Noncompaction Cardiomyopathy as a Potential Cause of Bilateral Posterior Cerebral Artery Stroke - a Rare and Unique Clinical Occurrence. Am J Case Rep. 2021 Jun 22; 22:e931103. PMID: 34157014.
      Citations:    Fields:    Translation:Humans
    42. Basso U, Facchinetti A, Rossi E, Maruzzo M, Conteduca V, Aieta M, Massari F, Fraccon AP, Mucciarini C, Sava T, Santoni M, Pegoraro C, Durante E, Nicodemo M, Perin A, Bearz A, Gatti C, Fiduccia P, Diminutto A, Barile C, De Giorgi U, Zamarchi R, Zagonel V. Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial. Oncologist. 2021 09; 26(9):740-750. PMID: 34077597.
      Citations: 4     Fields:    Translation:HumansCells
    43. Santoni M, Rizzo A, Mollica V, Rosellini M, Marchetti A, Fragomeno B, Battelli N, Massari F. Pembrolizumab plus lenvatinib or axitinib compared to nivolumab plus ipilimumab or cabozantinib in advanced renal cell carcinoma: a number needed to treat analysis. Expert Rev Pharmacoecon Outcomes Res. 2022 Jan; 22(1):45-51. PMID: 34058953.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    44. Marchetti A, Rosellini M, Mollica V, Rizzo A, Tassinari E, Nuvola G, Cimadamore A, Santoni M, Fiorentino M, Montironi R, Massari F. The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What's the Story Morning Glory? Int J Mol Sci. 2021 Jun 09; 22(12). PMID: 34207825.
      Citations:    Fields:    Translation:Humans
    45. Cimadamore A, Cheng L, Massari F, Santoni M, Pepi L, Franzese C, Scarpelli M, Lopez-Beltran A, Galosi AB, Montironi R. Circulating Tumor DNA Testing for Homology Recombination Repair Genes in Prostate Cancer: From the Lab to the Clinic. Int J Mol Sci. 2021 May 24; 22(11). PMID: 34073818.
      Citations: 3     Fields:    Translation:HumansCells
    46. Santoni M, Massari F, Montironi R, Battelli N. Manipulating macrophage polarization in cancer patients: From nanoparticles to human chimeric antigen receptor macrophages. Biochim Biophys Acta Rev Cancer. 2021 08; 1876(1):188547. PMID: 33932561.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    47. Rizzo A, Mollica V, Santoni M, Rosellini M, Marchetti A, Ricci AD, Grilli G, Greco A, Montironi R, Ardizzoni A, Massari F. Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: a meta-analysis. Immunotherapy. 2021 06; 13(9):783-793. PMID: 33906376.
      Citations:    Fields:    Translation:Humans
    48. Rizzo A, Mollica V, Dall'Olio FG, Ricci AD, Maggio I, Marchetti A, Rosellini M, Santoni M, Ardizzoni A, Massari F. Quality of life assessment in renal cell carcinoma Phase II and III clinical trials published between 2010 and 2020: a systematic review. Future Oncol. 2021 Jul; 17(20):2671-2681. PMID: 33880963.
      Citations:    Fields:    Translation:Humans
    49. Rizzo A, Mollica V, Rosellini M, Marchetti A, Ricci AD, Fiorentino M, Battelli N, Santoni M, Massari F. Exploring the association between metastatic sites and androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer patients: A meta-analysis of prospective clinical trials. Pathol Res Pract. 2021 Jun; 222:153440. PMID: 33857854.
      Citations: 1     Fields:    Translation:HumansCells
    50. Akamatsu Y, Gomez-Paz S, Vergara-Garcia D, Moholkar VM, Kuhn AL, Chida K, Singh J, Rodrigues KM, Massari F, Moore JM, Puri AS, Ogilvy CS, Thomas AJ. Role of Surgical Intervention for Intracranial Dural Arteriovenous Fistulas With Cortical Venous Drainage in an Endovascular Era: A Case Series. Oper Neurosurg (Hagerstown). 2021 03 15; 20(4):364-372. PMID: 33378448.
      Citations: 1     Fields:    Translation:Humans
    51. Rizzo A, Mollica V, Santoni M, Ricci AD, Rosellini M, Marchetti A, Montironi R, Ardizzoni A, Massari F. Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials. Eur Urol Focus. 2022 Mar; 8(2):514-521. PMID: 33714725.
      Citations: 22     Fields:    Translation:Humans
    52. Rizzo A, Mollica V, Cimadamore A, Santoni M, Scarpelli M, Schiavina R, Cheng L, Lopez-Beltran A, Brunocilla E, Montironi R, Massari F. TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?-a narrative review. Transl Androl Urol. 2021 Mar; 10(3):1541-1552. PMID: 33850788.
      Citations:    
    53. Santoni M, Cimadamore A, Massari F, Sorgentoni G, Cheng L, Lopez-Beltran A, Battelli N, Montironi R. Narrative review: predicting future molecular and clinical profiles of prostate cancer in the United States. Transl Androl Urol. 2021 Mar; 10(3):1562-1568. PMID: 33850790.
      Citations:    
    54. Mollica V, Rizzo A, Di Nunno V, Santoni M, Cheng L, Lopez-Beltran A, Scarpelli M, Cimadamore A, Montironi R, Massari F. Adjuvant therapy in renal cell carcinoma: is it the right strategy to inhibit VEGF? Transl Androl Urol. 2021 Mar; 10(3):1581-1587. PMID: 33850792.
      Citations:    
    55. Aurilio G, Cimadamore A, Lopez-Beltran A, Scarpelli M, Massari F, Verri E, Cheng L, Santoni M, Montironi R. Narrative review: update on immunotherapy and pathological features in patients with bladder cancer. Transl Androl Urol. 2021 Mar; 10(3):1521-1529. PMID: 33850786.
      Citations:    
    56. Cimadamore A, Cheng L, Scarpelli M, Massari F, Mollica V, Santoni M, Lopez-Beltran A, Montironi R, Moch H. Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative review. Transl Androl Urol. 2021 Mar; 10(3):1506-1520. PMID: 33850785.
      Citations:    
    57. Montironi R, Cheng L, Cimadamore A, Mazzucchelli R, Scarpelli M, Santoni M, Massari F, Lopez-Beltran A. Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups? Transl Androl Urol. 2021 Mar; 10(3):1530-1540. PMID: 33850787.
      Citations:    
    58. Santoni M, Miccini F, Cimadamore A, Piva F, Massari F, Cheng L, Lopez-Beltran A, Montironi R, Battelli N. An update on investigational therapies that target STAT3 for the treatment of cancer. Expert Opin Investig Drugs. 2021 Mar; 30(3):245-251. PMID: 33599169.
      Citations: 5     Fields:    Translation:HumansAnimals
    59. Massari F, Rizzo A, Mollica V, Santoni M. A brand-new CAR for macrophages: is it time to fire up the engines of a new era for the treatment of renal cell carcinoma? Future Oncol. 2021 May; 17(15):1839-1841. PMID: 33590766.
      Citations: 1     Fields:    Translation:HumansCells
    60. Rosellini M, Santoni M, Mollica V, Rizzo A, Cimadamore A, Scarpelli M, Storti N, Battelli N, Montironi R, Massari F. Treating Prostate Cancer by Antibody-Drug Conjugates. Int J Mol Sci. 2021 Feb 04; 22(4). PMID: 33557050.
      Citations: 5     Fields:    Translation:HumansAnimals
    61. Santoni M, Massari F, Santoni G, Cimadamore A, Montironi R, Battelli N. Re: Human Chimeric Antigen Receptor Macrophages for Cancer Immunotherapy. Eur Urol. 2021 06; 79(6):887-889. PMID: 33549360.
      Citations:    Fields:    Translation:HumansCells
    62. Mollica V, Rizzo A, Rosellini M, Marchetti A, Ricci AD, Cimadamore A, Scarpelli M, Bonucci C, Andrini E, Errani C, Santoni M, Montironi R, Massari F. Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art. Cancers (Basel). 2021 Feb 01; 13(3). PMID: 33535541.
      Citations:    
    63. Rizzo A, Mollica V, Massari F. Expression of Programmed Cell Death Ligand 1 as a Predictive Biomarker in Metastatic Urothelial Carcinoma Patients Treated with First-line Immune Checkpoint Inhibitors Versus Chemotherapy: A Systematic Review and Meta-analysis. Eur Urol Focus. 2022 Jan; 8(1):152-159. PMID: 33516645.
      Citations: 11     Fields:    Translation:Humans
    64. Santoni M, Massari F, Bracarda S, Procopio G, Milella M, De Giorgi U, Basso U, Aurilio G, Incorvaia L, Martignetti A, Rizzo M, Cartenì G, Grande E, Matrana MR, Crabb SJ, Vau N, Sorgentoni G, Cimadamore A, Montironi R, Battelli N. Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor? Diagnostics (Basel). 2021 Jan 18; 11(1). PMID: 33477676.
      Citations:    
    65. Lopez-Beltran A, Cimadamore A, Blanca A, Massari F, Vau N, Scarpelli M, Cheng L, Montironi R. Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer. Cancers (Basel). 2021 Jan 03; 13(1). PMID: 33401585.
      Citations:    
    66. Mollica V, Rizzo A, Tassinari E, Giunchi F, Schiavina R, Fiorentino M, Brunocilla E, Ardizzoni A, Massari F. Prognostic and predictive factors to nivolumab in patients with metastatic renal cell carcinoma: a single center study. Anticancer Drugs. 2021 01 01; 32(1):74-81. PMID: 33290315.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    67. Aurilio G, Cimadamore A, Mazzucchelli R, Lopez-Beltran A, Verri E, Scarpelli M, Massari F, Cheng L, Santoni M, Montironi R. Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications. Cells. 2020 12 10; 9(12). PMID: 33321757.
      Citations: 23     Fields:    Translation:HumansCells
    68. Santoni M, Piva F, Porta C, Bracarda S, Heng DY, Matrana MR, Grande E, Mollica V, Aurilio G, Rizzo M, Giulietti M, Montironi R, Massari F. Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States. Clin Genitourin Cancer. 2021 04; 19(2):e84-e91. PMID: 33262083.
      Citations: 7     Fields:    Translation:Humans
    69. Levy J, Hopkins T, Morris J, Tran ND, David E, Massari F, Farid H, Vogel A, O'Connell WG, Sunenshine P, Dixon R, Gangi A, von der Höh N, Bagla S. Radiofrequency Ablation for the Palliative Treatment of Bone Metastases: Outcomes from the Multicenter OsteoCool Tumor Ablation Post-Market Study (OPuS One Study) in 100 Patients. J Vasc Interv Radiol. 2020 Nov; 31(11):1745-1752. PMID: 33129427.
      Citations: 15     Fields:    Translation:Humans
    70. Zong Y, Montironi R, Massari F, Jiang Z, Lopez-Beltran A, Wheeler TM, Scarpelli M, Santoni M, Cimadamore A, Cheng L. Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives. Eur Urol Focus. 2021 09; 7(5):955-963. PMID: 33132109.
      Citations: 2     Fields:    Translation:Humans
    71. Kühn AL, Singh J, de Macedo Rodrigues K, Massari F, Moholkar VM, Marwah SK, Unar D, Gounis MJ, Puri AS. Distal radial artery (Snuffbox) access for intracranial aneurysm treatment using the Woven EndoBridge (WEB) device. J Clin Neurosci. 2020 Nov; 81:310-315. PMID: 33222936.
      Citations: 1     Fields:    Translation:Humans
    72. Cimadamore A, Cheng L, Scarpelli M, Lopez-Beltran A, Mollica V, Montironi R, Massari F. Re: Alfonso Gómez de Liaño Lista, Nick van Dijk, Guillermo de Velasco Oria de Rueda, et al. Clinical Outcome After Progressing to Frontline and Second-line Anti-PD-1/PD-L1 in Advanced Urothelial Cancer. Eur Urol 2020;77:269-76: Progression and Hyperprogression Versus Pseudoprogression: Morphologic Documentation. Eur Urol. 2021 01; 79(1):e17-e19. PMID: 33067017.
      Citations:    Fields:    Translation:Humans
    73. Iacovelli R, Ciccarese C, Facchini G, Milella M, Urbano F, Basso U, De Giorgi U, Sabbatini R, Santini D, Berardi R, Santoni M, Bracarda S, Massari F, Masini C, De Tursi M, Ricotta R, Buti S, Zustovich F, Sepe P, Rossetti S, Maruzzo M, Cortesi E, Tortora G, Procopio G. Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis. Target Oncol. 2020 Oct; 15(5):691. PMID: 32857328.
      Citations:    Fields:    
    74. Santoni M, Massari F, Aurilio G, Mollica V, Cimadamore A, Lopez-Beltran A, Cheng L, Battelli N, Nolé F, Montironi R. Designing novel immunocombinations in metastatic renal cell carcinoma. Immunotherapy. 2020 12; 12(17):1257-1268. PMID: 32998603.
      Citations: 2     Fields:    Translation:Humans
    75. Kühn AL, Singh J, Moholkar VM, Satti SR, Rodrigues KM, Massari F, Gounis MJ, McGowan A, Puri AS. Distal radial artery (snuffbox) access for carotid artery stenting - Technical pearls and procedural set-up. Interv Neuroradiol. 2021 Apr; 27(2):241-248. PMID: 32924692.
      Citations: 1     Fields:    Translation:Humans
    76. Rizzo A, Mollica V, Cimadamore A, Santoni M, Scarpelli M, Giunchi F, Cheng L, Lopez-Beltran A, Fiorentino M, Montironi R, Massari F. Is There a Role for Immunotherapy in Prostate Cancer? Cells. 2020 09 08; 9(9). PMID: 32911806.
      Citations: 19     Fields:    Translation:Humans
    77. Loriot Y, Sternberg CN, Castellano D, Oosting SF, Dumez H, Huddart R, Vianna K, Alonso Gordoa T, Skoneczna I, Fay AP, Nolè F, Massari F, Brasiuniene B, Maroto P, Fear S, Di Nucci F, de Ducla S, Choy E. Safety and efficacy of atezolizumab in patients with autoimmune disease: Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma. Eur J Cancer. 2020 10; 138:202-211. PMID: 32905959.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    78. Mollica V, Maggio I, Lopez-Beltran A, Montironi R, Cimadamore A, Cheng L, Rizzo A, Giunchi F, Schiavina R, Fiorentino M, Brunocilla E, Massari F. Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitors. Expert Rev Anticancer Ther. 2020 09; 20(9):755-763. PMID: 32757789.
      Citations: 4     Fields:    Translation:Humans
    79. Iacovelli R, Ciccarese C, Facchini G, Milella M, Urbano F, Basso U, De Giorgi U, Sabbatini R, Santini D, Berardi R, Santoni M, Bracarda S, Massari F, Masini C, De Tursi M, Ricotta R, Buti S, Zustovich F, Sepe P, Rossetti S, Maruzzo M, Cortesi E, Tortora G, Procopio G. Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis. Target Oncol. 2020 08; 15(4):495-501. PMID: 32671807.
      Citations: 6     Fields:    Translation:Humans
    80. Kuhn AL, Puri AS, De Macedo Rodrigues K, Massari F, Singh J. Trapped Embolic Protection Device: A Salvage Technique. Cureus. 2020 Jul 16; 12(7):e9228. PMID: 32821577.
      Citations:    
    81. Aurilio G, Cimadamore A, Santoni M, Nolè F, Scarpelli M, Massari F, Lopez-Beltran A, Cheng L, Montironi R. New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents? Cells. 2020 06 22; 9(6). PMID: 32580469.
      Citations: 5     Fields:    Translation:Humans
    82. Conteduca V, Caffo O, Scarpi E, Sepe P, Galli L, Fratino L, Maines F, Chiuri VE, Santoni M, Zanardi E, Massari F, Toma I, Lolli C, Schepisi G, Sbrana A, Kinspergher S, Cursano MC, Casadei C, Modonesi C, Santini D, Procopio G, De Giorgi U. Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy. J Clin Med. 2020 Jun 22; 9(6). PMID: 32580478.
      Citations:    
    83. Cimadamore A, Aurilio G, Nolé F, Massari F, Scarpelli M, Santoni M, Lopez-Beltran A, Cheng L, Montironi R. Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer. Cells. 2020 06 19; 9(6). PMID: 32575429.
      Citations: 5     Fields:    Translation:HumansCells
    84. Mollica V, Rizzo A, Montironi R, Cheng L, Giunchi F, Schiavina R, Santoni M, Fiorentino M, Lopez-Beltran A, Brunocilla E, Brandi G, Massari F. Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma. Cancers (Basel). 2020 Jun 02; 12(6). PMID: 32498352.
      Citations:    
    85. Donini M, Buti S, Massari F, Mollica V, Rizzo A, Montironi R, Bersanelli M, Santoni M. Management of oligometastatic and oligoprogressive renal cell carcinoma: state of the art and future directions. Expert Rev Anticancer Ther. 2020 06; 20(6):491-501. PMID: 32479120.
      Citations: 3     Fields:    Translation:Humans
    86. Montironi R, Cimadamore A, Lopez-Beltran A, Scarpelli M, Aurilio G, Santoni M, Massari F, Cheng L. Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer. Cells. 2020 04 25; 9(5). PMID: 32344931.
      Citations: 9     Fields:    Translation:Humans
    87. Di Nunno V, Santoni M, Mollica V, Conti A, Montironi R, Battelli N, Ardizzoni A, Massari F. Systemic Treatment for Metastatic Hormone Sensitive Prostate Cancer: A Comprehensive Meta-Analysis Evaluating Efficacy and Safety in Specific Sub-Groups of Patients. Clin Drug Investig. 2020 Mar; 40(3):211-226. PMID: 31993991.
      Citations: 3     Fields:    Translation:Humans
    88. Cimadamore A, Scarpelli M, Massari F, Eckstein M, Gevaert T, Cheng L, Lopez-Beltran A, Montironi R. Immunotherapy for urothelial cancer: from the diagnostic pathologist's point of view. Expert Opin Biol Ther. 2020 06; 20(6):539-544. PMID: 32081061.
      Citations: 3     Fields:    Translation:Humans
    89. Cimadamore A, Lopez-Beltran A, Massari F, Santoni M, Mazzucchelli R, Scarpelli M, Galosi AB, Cheng L, Montironi R. Germline and somatic mutations in prostate cancer: focus on defective DNA repair, PARP inhibitors and immunotherapy. Future Oncol. 2020 Feb; 16(5):75-80. PMID: 31916449.
      Citations: 5     Fields:    Translation:HumansCells
    90. Kühn AL, de Macedo Rodrigues K, Singh J, Massari F, Puri AS. Distal radial access in the anatomical snuffbox for neurointerventions: a feasibility, safety, and proof-of-concept study. J Neurointerv Surg. 2020 Aug; 12(8):798-801. PMID: 31915209.
      Citations: 9     Fields:    Translation:Humans
    91. Mollica V, Santoni M, Di Nunno V, Cimadamore A, Cheng L, Lopez-Beltran A, Battelli N, Montironi R, Massari F. Immunotherapy and Radiation Therapy in Renal Cell Carcinoma. Curr Drug Targets. 2020; 21(14):1463-1475. PMID: 32160846.
      Citations:    Fields:    Translation:HumansAnimals
    92. Santoni M, Massari F, Cheng L, Cimadamore A, Scarpelli M, Montironi R, Lopez-Beltran A. PD-L1 Inhibitors for the Treatment of Prostate Cancer. Curr Drug Targets. 2020; 21(15):1558-1565. PMID: 32516098.
      Citations: 1     Fields:    Translation:HumansAnimals
    93. Cimadamore A, Massari F, Santoni M, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R, Moch H. PD1 and PD-L1 Inhibitors for the Treatment of Kidney Cancer: The Role of PD-L1 Assay. Curr Drug Targets. 2020; 21(16):1664-1671. PMID: 32208115.
      Citations: 1     Fields:    Translation:Humans
    94. Santoni M, Heng DY, Bracarda S, Procopio G, Milella M, Porta C, Matrana MR, Cartenì G, Crabb SJ, De Giorgi U, Basso U, Masini C, Calabrò F, Vitale MG, Santini D, Massari F, Galli L, Fornarini G, Ricotta R, Buti S, Zucali P, Caffo O, Morelli F, Carrozza F, Martignetti A, Gelibter A, Iacovelli R, Mosca A, Atzori F, Vau N, Incorvaia L, Ortega C, Scarpelli M, Lopez-Beltran A, Cheng L, Paolucci V, Graham J, Pierce E, Scagliarini S, Sepe P, Verzoni E, Merler S, Rizzo M, Sorgentoni G, Conti A, Piva F, Cimadamore A, Montironi R, Battelli N. Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors. Cancers (Basel). 2019 Dec 30; 12(1). PMID: 31905816.
      Citations:    
    95. Santoni M, Conti A, Massari F, Di Nunno V, Faloppi L, Galizia E, Morbiducci J, Piva F, Buti S, Iacovelli R, Ferretti B, Cimadamore A, Scarpelli M, Lopez-Beltran A, Cheng L, Battelli N, Montironi R. Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies. Expert Rev Cardiovasc Ther. 2019 Dec; 17(12):917-927. PMID: 31829045.
      Citations: 1     Fields:    Translation:Humans
    96. Lopez-Beltran A, Cheng L, Gevaert T, Blanca A, Cimadamore A, Santoni M, Massari F, Scarpelli M, Raspollini MR, Montironi R. Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers. Expert Rev Mol Diagn. 2020 02; 20(2):231-243. PMID: 31795775.
      Citations: 7     Fields:    Translation:HumansCells
    97. Massari F, Nunno VD, Mollica V, Montironi R, Cheng L, Cimadamore A, Blanca A, Lopez-Beltran A. Immunotherapy in renal cell carcinoma from poverty to the spoiled of choice. Immunotherapy. 2019 12; 11(17):1507-1521. PMID: 31663411.
      Citations: 3     Fields:    Translation:Humans
    98. Mollica V, Di Nunno V, Santoni M, Cimadamore A, Scarpelli M, Lopez-Beltran A, Cheng L, Mariani C, Battelli N, Montironi R, Massari F. An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer. Expert Rev Mol Diagn. 2020 02; 20(2):207-217. PMID: 31640441.
      Citations: 3     Fields:    Translation:HumansCells
    99. Kouba E, Lopez-Beltran A, Montironi R, Massari F, Huang K, Santoni M, Chovanec M, Cheng M, Scarpelli M, Zhang J, Cimadamore A, Cheng L. Liquid biopsy in the clinical management of bladder cancer: current status and future developments. Expert Rev Mol Diagn. 2020 02; 20(2):255-264. PMID: 31608720.
      Citations: 5     Fields:    Translation:HumansCells
    100. Di Nunno V, Mollica V, Brunelli M, Gatto L, Schiavina R, Fiorentino M, Santoni M, Montironi R, Caliò A, Eccher A, Milella M, Martignoni G, Brunocilla E, Massari F. A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss. Mol Diagn Ther. 2019 10; 23(5):569-577. PMID: 31332726.
      Citations: 5     Fields:    Translation:HumansCells
    101. Cimadamore A, Scarpelli M, Raspollini MR, Doria A, Galosi AB, Massari F, Di Nunno V, Cheng L, Lopez-Beltran A, Montironi R. Prostate cancer pathology: What has changed in the last 5 years. Urologia. 2020 Feb; 87(1):3-10. PMID: 31545701.
      Citations: 1     Fields:    Translation:Humans
    102. Cimadamore A, Massari F, Santoni M, Mollica V, Di Nunno V, Cheng L, Lopez-Beltran A, Scarpelli M, Montironi R, Moch H. Molecular characterization and diagnostic criteria of renal cell carcinoma with emphasis on liquid biopsies. Expert Rev Mol Diagn. 2020 02; 20(2):141-150. PMID: 31498685.
      Citations: 6     Fields:    Translation:HumansCells
    103. Cimadamore A, Santoni M, Massari F, Cheng L, Lopez-Beltran A, Scarpelli M, Montironi R. Liquid biopsies in renal cell carcinoma with focus on epigenome analysis. Ann Transl Med. 2019 Sep; 7(Suppl 6):S194. PMID: 31656773.
      Citations:    
    104. Santoni M, Cimadamore A, Massari F, Piva F, Aurilio G, Martignetti A, Scarpelli M, Di Nunno V, Gatto L, Battelli N, Cheng L, Lopez-Beltran A, Montironi R. Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate Cancers. Cancers (Basel). 2019 Aug 22; 11(9). PMID: 31443386.
      Citations:    
    105. Di Nunno V, Mollica V, Schiavina R, Nobili E, Fiorentino M, Brunocilla E, Ardizzoni A, Massari F. Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma. Clin Genitourin Cancer. 2020 04; 18(2):e83-e90. PMID: 31753738.
      Citations: 5     Fields:    Translation:Humans
    106. Massari F, Di Nunno V, Santoni M, Gatto L, Caserta C, Morelli F, Zafarana E, Carrozza F, Mosca A, Mollica V, Iacovelli R, Sabbatini R, Porta C, Bracarda S. Toward a genome-based treatment landscape for renal cell carcinoma. Crit Rev Oncol Hematol. 2019 Oct; 142:141-152. PMID: 31401421.
      Citations: 6     Fields:    Translation:HumansAnimals
    107. Di Nunno V, Mollica V, Santoni M, Gatto L, Schiavina R, Fiorentino M, Brunocilla E, Ardizzoni A, Massari F. New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes. Clin Genitourin Cancer. 2019 10; 17(5):e871-e877. PMID: 31378578.
      Citations: 9     Fields:    Translation:Humans
    108. Di Nunno V, Massari F, Mollica V, Cimadamore A, Santoni M, Cheng L, Lopez-Beltran A, Scarpelli M, Montironi R. Another one in the chamber: cabozantinib for patients with metastatic non clear cell renal cell carcinoma. Ann Transl Med. 2019 Jul; 7(Suppl 3):S137. PMID: 31576344.
      Citations:    
    109. Mollica V, Di Nunno V, Gatto L, Santoni M, Scarpelli M, Cimadamore A, Lopez-Beltran A, Cheng L, Battelli N, Montironi R, Massari F. Resistance to Systemic Agents in Renal Cell Carcinoma Predict and Overcome Genomic Strategies Adopted by Tumor. Cancers (Basel). 2019 Jun 14; 11(6). PMID: 31207938.
      Citations:    
    110. Di Nunno V, Frega G, Santoni M, Gatto L, Fiorentino M, Montironi R, Battelli N, Brandi G, Massari F. BAP1 in solid tumors. Future Oncol. 2019 Jun; 15(18):2151-2162. PMID: 31159579.
      Citations: 8     Fields:    Translation:HumansAnimals
    111. Mollica V, Di Nunno V, Gatto L, Santoni M, Cimadamore A, Cheng L, Lopez-Beltran A, Montironi R, Pisconti S, Battelli N, Massari F. Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution. Clin Drug Investig. 2019 Jun; 39(6):503-519. PMID: 30937824.
      Citations: 10     Fields:    Translation:Humans
    112. Nunno VD, Mollica V, Gatto L, Santoni M, Cosmai L, Porta C, Massari F. Prognostic impact of neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis. Immunotherapy. 2019 05; 11(7):631-643. PMID: 30943858.
      Citations: 12     Fields:    Translation:HumansCells
    113. Santoni M, Cimadamore A, Cheng L, Lopez-Beltran A, Battelli N, Massari F, Scarpelli M, Galosi AB, Bracarda S, Montironi R. Circulating Tumor Cells in Renal Cell Carcinoma: Recent Findings and Future Challenges. Front Oncol. 2019; 9:228. PMID: 31024837.
      Citations:    
    114. Massari F, Mollica V, Di Nunno V, Gatto L, Santoni M, Scarpelli M, Cimadamore A, Lopez-Beltran A, Cheng L, Battelli N, Montironi R, Brandi G. The Human Microbiota and Prostate Cancer: Friend or Foe? Cancers (Basel). 2019 Mar 31; 11(4). PMID: 30935126.
      Citations:    
    115. Cimadamore A, Santoni M, Massari F, Gasparrini S, Cheng L, Lopez-Beltran A, Montironi R, Scarpelli M. Microbiome and Cancers, With Focus on Genitourinary Tumors. Front Oncol. 2019; 9:178. PMID: 30972292.
      Citations:    
    116. Di Nunno V, Santoni M, Gatto L, Mollica V, Massari F. Re: Christopher C. Parker, Nicholas D. James, Christopher D. Brawley, et al. Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE): A Randomised Controlled Phase 3 Trial. Lancet 2018;392:2353-66: Metastatic Hormone-naïve Prostate Cancer: A Multimodal Approach for a Heterogeneous Disease. Eur Urol Oncol. 2020 06; 3(3):390. PMID: 31411989.
      Citations:    Fields:    Translation:Humans
    117. Di Nunno V, Mollica V, Gatto L, Santoni M, Sorgentoni G, Battelli N, Massari F. Adjuvant therapy in renal cell carcinoma-is pharmacogenomics assessment another element to select our patients? Ann Transl Med. 2019 Mar; 7(Suppl 1):S38. PMID: 31032317.
      Citations:    
    118. Santoni M, Maiorani G, Faloppi L, Di Nunno V, Gatto L, Massari F, Battelli N. Optimizing renal function and outcome of patients with cT2 renal cell carcinoma. Ann Transl Med. 2019 Mar; 7(Suppl 1):S39. PMID: 31032318.
      Citations:    
    119. Cimadamore A, Gasparrini S, Massari F, Santoni M, Cheng L, Lopez-Beltran A, Scarpelli M, Montironi R. Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy. Cancers (Basel). 2019 Feb 07; 11(2). PMID: 30736478.
      Citations:    
    120. Massari F, Di Nunno V, Santoni M, Gatto L, Mollica V, Porta C. Re: Bimal Bhindi, E. Jason Abel, Laurence Albiges, et al. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. Eur Urol 2019;75:111-28: Cytoreductive Nephrectomy in the Targeted Therapy Era: This is Not the End. Eur Urol Oncol. 2019 09; 2(5):603-604. PMID: 31411982.
      Citations:    Fields:    Translation:Humans
    121. Mollica V, Di Nunno V, Cimadamore A, Lopez-Beltran A, Cheng L, Santoni M, Scarpelli M, Montironi R, Massari F. Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer. Cells. 2019 01 11; 8(1). PMID: 30642011.
      Citations: 19     Fields:    Translation:Humans
    122. Cimadamore A, Scarpelli M, Santoni M, Massari F, Tartari F, Cerqueti R, Lopez-Beltran A, Cheng L, Montironi R. Genitourinary Tumors: Update on Molecular Biomarkers for Diagnosis, Prognosis and Prediction of Response to Therapy. Curr Drug Metab. 2019; 20(4):305-312. PMID: 30799789.
      Citations: 3     Fields:    Translation:Humans
    123. Cimadamore A, Cheng M, Santoni M, Lopez-Beltran A, Battelli N, Massari F, Galosi AB, Scarpelli M, Montironi R. New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen. Front Oncol. 2018; 8:653. PMID: 30622933.
      Citations:    
    124. Massari F, Di Nunno V, Gatto L, Santoni M, Schiavina R, Cosmai L, Brunocilla E, Ardizzoni A, Porta C. Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy. Target Oncol. 2018 12; 13(6):705-714. PMID: 30324488.
      Citations: 11     Fields:    Translation:Humans
    125. Saeed O, Lopez-Beltran A, Fisher KW, Scarpelli M, Montironi R, Cimadamore A, Massari F, Santoni M, Cheng L. RAS genes in colorectal carcinoma: pathogenesis, testing guidelines and treatment implications. J Clin Pathol. 2019 Feb; 72(2):135-139. PMID: 30425122.
      Citations: 11     Fields:    Translation:Humans
    126. Di Nunno V, Gatto L, Fragomeno B, Cubelli M, Nobili E, Romano I, Santoni M, Pisconti S, Montironi R, Massari F. Combination immunotherapy in metastatic renal cell carcinoma. Are we leaving something back? Future Oncol. 2018 Dec; 14(29):2997-2999. PMID: 30411632.
      Citations: 2     Fields:    Translation:Humans
    127. Lopez-Beltran A, Henriques V, Cimadamore A, Santoni M, Cheng L, Gevaert T, Blanca A, Massari F, Scarpelli M, Montironi R. The Identification of Immunological Biomarkers in Kidney Cancers. Front Oncol. 2018; 8:456. PMID: 30450335.
      Citations:    
    128. Santoni M, Montironi R, Battelli N, Massari F. Reply to Michael Staehler, Dena Battle, Axel Bex, Hans Hammers, and Daniel George's Letter to the Editor re: Arnaud Méjean, Alain Ravaud, Simon Thezenas, et al. Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma. Eur Urol 2018;74:842-3: Lymphocyte Phenotype and Timing of Radical Nephrectomy in Patients Treated with Immunocheckpoint Inhibitors for Renal Cell Carcinoma. Eur Urol. 2019 03; 75(3):e64-e66. PMID: 30391082.
      Citations: 1     Fields:    Translation:HumansCells
    129. Bersanelli M, Giannarelli D, Castrignanò P, Fornarini G, Panni S, Mazzoni F, Tiseo M, Rossetti S, Gambale E, Rossi E, Papa A, Cortellini A, Lolli C, Ratta R, Michiara M, Milella M, De Luca E, Sorarù M, Mucciarini C, Atzori F, Banna GL, La Torre L, Vitale MG, Massari F, Rebuzzi SE, Facchini G, Schinzari G, Tomao S, Bui S, Vaccaro V, Procopio G, De Giorgi U, Santoni M, Ficorella C, Sabbatini R, Maestri A, Natoli C, De Tursi M, Di Maio M, Rapacchi E, Pireddu A, Sava T, Lipari H, Comito F, Verzoni E, Leonardi F, Buti S. INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. Immunotherapy. 2018 10; 10(14):1229-1239. PMID: 30326787.
      Citations: 16     Fields:    Translation:HumansCellsPHPublic Health
    130. Di Nunno V, Gatto L, Santoni M, Cimadamore A, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R, Massari F. Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer. Front Oncol. 2018; 8:397. PMID: 30319966.
      Citations:    
    131. Di Nunno V, Santoni M, Massari F. New Hormonal Agents in Patients with Nonmetastatic Castration-resistant Prostate Cancer: Can We Be Satisfied with an Advantage in Metastasis-free Survival? Eur Urol Oncol. 2019 07; 2(4):471. PMID: 31277785.
      Citations: 1     Fields:    Translation:Humans
    132. Di Nunno V, Santoni M, Massari F. Is combining PARP and androgen receptor inhibition really a winning strategy in metastatic castration-resistant prostate cancer? Lancet Oncol. 2018 09; 19(9):e437. PMID: 30191844.
      Citations:    Fields:    Translation:Humans
    133. Di Nunno V, Cimadamore A, Santoni M, Scarpelli M, Fiorentino M, Ciccarese C, Iacovelli R, Cheng L, Lopez-Beltran A, Massari F, Montironi R. Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer. Future Oncol. 2018 Oct; 14(25):2559-2564. PMID: 30141348.
      Citations: 3     Fields:    Translation:Humans
    134. Massari F, Di Nunno V, Santoni M. Re: Arnaud Méjean, Alain Ravaud, Simon Thezenas, et al. Sunitinib Alone or After Nephrectomy in Metastatic Renal-cell Carcinoma. N Engl J Med 2018;379:417-27: CARMENA Trial: Is This the End of Cytoreductive Nephrectomy in Patients with Clear-cell Renal Cell Carcinoma? Eur Urol Oncol. 2019 05; 2(3):340-341. PMID: 31200852.
      Citations:    Fields:    Translation:Humans
    135. Di Nunno V, Santoni M, Cimadamore A, Battelli N, Massari F. Re: Gladell P. Paner, Walter M. Stadler, Donna E. Hansel, Rodolfo Montironi, Daniel W. Lin, Mahul B. Amin. Updates in the Eighth Edition of the Tumor-node-metastasis Staging Classification for Urologic Cancers. Eur Urol 2018;73:560-9: Tumour, Node, and Metastasis Staging System for Urological Malignancies: Are We Ready for the Next Step? Eur Urol. 2018 11; 74(5):e118-e119. PMID: 30017397.
      Citations: 1     Fields:    Translation:Humans
    136. Cimadamore A, Gasparrini S, Santoni M, Cheng L, Lopez-Beltran A, Battelli N, Massari F, Giunchi F, Fiorentino M, Scarpelli M, Montironi R. Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer. Expert Rev Mol Diagn. 2018 07; 18(7):645-655. PMID: 29912582.
      Citations: 13     Fields:    Translation:Humans
    137. Massari F, Santoni M, di Nunno V, Cheng L, Lopez-Beltran A, Cimadamore A, Gasparrini S, Scarpelli M, Battelli N, Montironi R. Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies. Cancer Treat Rev. 2018 Jul; 68:80-85. PMID: 29886353.
      Citations: 11     Fields:    Translation:Humans
    138. Santoni M, Massari F, Di Nunno V, Conti A, Cimadamore A, Scarpelli M, Montironi R, Cheng L, Battelli N, Lopez-Beltran A. Immunotherapy in renal cell carcinoma: latest evidence and clinical implications. Drugs Context. 2018; 7:212528. PMID: 29899754.
      Citations:    
    139. Santoni M, Massari F, Piva F, Carrozza F, Di Nunno V, Cimadamore A, Martignetti A, Montironi R, Battelli N. Tivozanib for the treatment of renal cell carcinoma. Expert Opin Pharmacother. 2018 Jun; 19(9):1021-1025. PMID: 29851529.
      Citations: 5     Fields:    Translation:Humans
    140. Mosillo C, Ciccarese C, Bimbatti D, Fantinel E, Volta AD, Bisogno I, Zampiva I, Santoni M, Massari F, Brunelli M, Montironi R, Tortora G, Iacovelli R. Renal cell carcinoma in one year: Going inside the news of 2017 - A report of the main advances in RCC cancer research. Cancer Treat Rev. 2018 Jun; 67:29-33. PMID: 29753244.
      Citations: 2     Fields:    Translation:Humans
    141. Montironi R, Cimadamore A, Gasparrini S, Mazzucchelli R, Santoni M, Massari F, Cheng L, Lopez-Beltran A, Scarpelli M. Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma. Expert Rev Anticancer Ther. 2018 07; 18(7):685-693. PMID: 29699428.
      Citations: 3     Fields:    Translation:Humans
    142. Di Nunno V, Santoni M, Massari F. Re: Michael B. Atkins, Elizabeth R. Plimack, Igor Puzanov, et al. Axitinib in Combination with Pembrolizumab in Patients with Advanced Renal Cell Cancer: A Non-randomised, Open-label, Dose-finding, and Dose-expansion Phase 1b Trial. Lancet Oncol 2018;19:405-15. Eur Urol. 2018 08; 74(2):e50. PMID: 29709313.
      Citations: 1     Fields:    Translation:Humans
    143. Procopio G, Prisciandaro M, Iacovelli R, Cortesi E, Fornarini G, Facchini G, Cartenì G, Sabbatini R, Del Bene G, Galli L, Caserta C, Multari AG, Bregni M, Massari F, Buti S, De Giorgi U, Zustovich F, Milella M, Calabrò F, Mancini ML, Tortora G, Vernieri C, Santini D, Sorarù M, Ricotta R, Masini C, Tucci M, Fedeli SL, Ortega C, Mecozzi A, Ratta R, Sternberg CN, Verzoni E. Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program. Clin Genitourin Cancer. 2018 08; 16(4):e945-e951. PMID: 29753637.
      Citations: 6     Fields:    Translation:Humans
    144. De Macedo Rodrigues K, Kühn AL, Tamura T, Dabus G, Kan P, Marosfoi MG, Lozano JD, Perras M, Brooks C, Howk MC, Hou SY, Rex DE, Massari F, Gounis MJ, Wakhloo AK, Puri AS. Pipeline Embolization Device for Pericallosal Artery Aneurysms: A Retrospective Single Center Safety and Efficacy Study. Oper Neurosurg (Hagerstown). 2018 04 01; 14(4):351-358. PMID: 28521024.
      Citations: 5     Fields:    Translation:Humans
    145. Massari F, Di Nunno V, Cubelli M, Santoni M, Fiorentino M, Montironi R, Cheng L, Lopez-Beltran A, Battelli N, Ardizzoni A. Immune checkpoint inhibitors for metastatic bladder cancer. Cancer Treat Rev. 2018 Mar; 64:11-20. PMID: 29407369.
      Citations: 34     Fields:    Translation:HumansAnimals
    146. Massari F, Di Nunno V, Comito F, Cubelli M, Ciccarese C, Iacovelli R, Fiorentino M, Montironi R, Ardizzoni A. Circulating tumor cells in genitourinary tumors. Ther Adv Urol. 2018 Feb; 10(2):65-77. PMID: 29434674.
      Citations:    
    147. Cheng L, Lopez-Beltran A, Massari F, MacLennan GT, Montironi R. Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine. Mod Pathol. 2018 01; 31(1):24-38. PMID: 29148538.
      Citations: 106     Fields:    Translation:Humans
    148. Montironi R, Cimadamore A, Massari F, Montironi MA, Lopez-Beltran A, Cheng L, Montorsi F, Scarpelli M. Whole Slide Imaging of Large Format Histology in Prostate Pathology: Potential for Information Fusion. Arch Pathol Lab Med. 2017 11; 141(11):1460-1461. PMID: 29072947.
      Citations: 4     Fields:    Translation:Humans
    149. Blanca A, Cheng L, Montironi R, Moch H, Massari F, Fiorentino M, Raspollini MR, Scarpelli M, Lopez-Beltran A. Mirna Expression in Bladder Cancer and Their Potential Role in Clinical Practice. Curr Drug Metab. 2017 Oct 16; 18(8):712-722. PMID: 28524002.
      Citations: 14     Fields:    Translation:Humans
    150. Giunchi F, Ciccarese C, Montironi R, Scarpelli M, Lopez-Beltran A, Cheng L, Moch H, Massari F, Fiorentino M. Urinary Biomarkers for Prostate Cancer. Curr Drug Metab. 2017 Oct 16; 18(8):723-726. PMID: 28524004.
      Citations: 3     Fields:    Translation:Humans
    151. Mann SA, Lopez-Beltran A, Massari F, Pili R, Fiorentino M, Koch MO, Kaimakliotis HZ, Wang L, Scarpelli M, Ciccarese C, Moch H, Montironi R, Cheng L. Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future Perspectives. Curr Drug Metab. 2017 Oct 16; 18(8):700-711. PMID: 28524003.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    152. Gasparrini S, Cimadamore A, Scarpelli M, Massari F, Doria A, Mazzucchelli R, Cheng L, Lopez-Beltran A, Montironi R. Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians. Asian J Androl. 2017 Aug 04. PMID: 28782737.
      Citations: 1     Fields:    
    153. Gasparrini S, Cimadamore A, Mazzucchelli R, Scarpelli M, Massari F, Raspollini MR, Galosi AB, Lopez-Beltran A, Cheng L, Montironi R. Pathology and molecular updates in tumors of the prostate: towards a personalized approach. Expert Rev Mol Diagn. 2017 08; 17(8):781-789. PMID: 28598696.
      Citations: 3     Fields:    Translation:Humans
    154. Montironi R, Gasparrini S, Lopez-Beltran A, Cheng L, Massari F, Montorsi F, Scarpelli M. Re: Umberto Leone Roberti Maggiore, Simone Ferrero, Massimo Candiani, et al. Bladder Endometriosis: A Systematic Review of Pathogenesis, Diagnosis, Treatment, Impact on Fertility, and Risk of Malignant Transformation. Eur Urol 2017;71:790-807. Eur Urol. 2017 11; 72(5):e139-e141. PMID: 28576502.
      Citations:    Fields:    Translation:Humans
    155. Iacovelli R, Cossu Rocca M, Galli L, De Giorgi U, Sabbatini R, Santoni M, Mosca A, Fornarini G, Massari F, Masini C, Bersanelli M, Biasco E, Lolli C, Guida A, Berardi R, Terrone C, Pastorino A, Ardizzoni A, Pinto C, Buti S, Nolè F, Tortora G. Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer. Urol Oncol. 2017 09; 35(9):541.e7-541.e13. PMID: 28572027.
      Citations: 3     Fields:    Translation:Humans
    156. Montironi R, Lopez-Beltran A, Cheng L, Gasparrini S, Montironi MA, Massari F, Scarpelli M, Montorsi F. Re: Kenneth A. Iczkowski's Letter to the Editor re: Re: Rodolfo Montironi, Silvia Gasparrini, Roberta Mazzucchelli, et al's Letter to the Editor re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738-9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides. Eur Urol 2017;71:e73-5. Eur Urol. 2017 08; 72(2):e37-e38. PMID: 28292549.
      Citations:    Fields:    Translation:Humans
    157. Ciccarese C, Massari F, Blanca A, Tortora G, Montironi R, Cheng L, Scarpelli M, Raspollini MR, Vau N, Fonseca J, Lopez-Beltran A. Tp53 and its potential therapeutic role as a target in bladder cancer. Expert Opin Ther Targets. 2017 Apr; 21(4):401-414. PMID: 28281901.
      Citations: 19     Fields:    Translation:HumansAnimals
    158. Ciccarese C, Massari F, Iacovelli R, Fiorentino M, Montironi R, Di Nunno V, Giunchi F, Brunelli M, Tortora G. Prostate cancer heterogeneity: Discovering novel molecular targets for therapy. Cancer Treat Rev. 2017 Mar; 54:68-73. PMID: 28231559.
      Citations: 33     Fields:    Translation:HumansCells
    159. Cimadamore A, Scarpelli M, Piva F, Massari F, Gasparrini S, Doria A, Cheng L, Lopez-Beltran A, Montironi R. Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets. Future Oncol. 2017 May; 13(12):1105-1114. PMID: 28147707.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    160. Fiorentino M, Gruppioni E, Massari F, Giunchi F, Altimari A, Ciccarese C, Bimbatti D, Scarpa A, Iacovelli R, Porta C, Virinder S, Tortora G, Artibani W, Schiavina R, Ardizzoni A, Brunelli M, Knuutila S, Martignoni G. Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach. Oncotarget. 2017 Jan 31; 8(5):7328-7335. PMID: 27741505.
      Citations: 10     Fields:    Translation:Humans
    161. Cimadamore A, Gasparrini S, Scarpelli M, Doria A, Mazzucchelli R, Massari F, Cheng L, Lopez-Beltran A, Montironi R. Epigenetic Modifications and Modulators in Prostate Cancer. Crit Rev Oncog. 2017; 22(5-6):439-450. PMID: 29604923.
      Citations: 6     Fields:    Translation:HumansCells
    162. Massari F, Ciccarese C, Bria E, Porta C, La Russa F, Knuutila S, Artibani W, Porcaro AB, Bimbatti D, Modena A, Sava T, Tortora G, Cheng L, Eccher A, Cima L, Pedron S, Ghimenton C, Martignoni G, Brunelli M. Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma. Appl Immunohistochem Mol Morphol. 2017 01; 25(1):39-43. PMID: 26509904.
      Citations: 5     Fields:    Translation:HumansCells
    163. Ciccarese C, Montironi R, Fiorentino M, Martignoni G, Brunelli M, Iacovelli R, Lopez-Beltran A, Cheng L, Scarpelli M, Moch H, Tortora G, Massari F. Circulating Tumor Cells: A Reliable Biomarker for Prostate Cancer Treatment Assessment? Curr Drug Metab. 2017; 18(8):692-699. PMID: 28524006.
      Citations: 4     Fields:    Translation:HumansCells
    164. Kühn AL, Wakhloo AK, Gounis MJ, Kan P, de Macedo Rodrigues K, Lozano JD, Marosfoi MG, Perras M, Brooks C, Howk MC, Rex DE, Massari F, Puri AS. Use of self-expanding stents for better intracranial flow diverter wall apposition. Interv Neuroradiol. 2017 Apr; 23(2):129-136. PMID: 27956518.
      Citations: 6     Fields:    Translation:Humans
    165. Kühn AL, de Macedo Rodrigues K, Lozano JD, Rex DE, Massari F, Tamura T, Howk M, Brooks C, L'Heureux J, Gounis MJ, Wakhloo AK, Puri AS. Use of the Pipeline embolization device for recurrent and residual cerebral aneurysms: a safety and efficacy analysis with short-term follow-up. J Neurointerv Surg. 2017 Dec; 9(12):1208-1213. PMID: 27888225.
      Citations: 8     Fields:    Translation:Humans
    166. Gasparrini S, Mazzucchelli R, Scarpelli M, Massari F, Raspollini MR, Lopez-Beltran A, Cheng L, Montironi R. Prostate cancer grading in 2016. Minerva Urol Nefrol. 2017 02; 69(1):1-4. PMID: 27813397.
      Citations:    Fields:    
    167. Montironi R, Gasparrini S, Mazzucchelli R, Massari F, Cheng L, Lopez-Beltran A, Montorsi F, Scarpelli M. Re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738-9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides. Eur Urol. 2017 02; 71(2):e73-e75. PMID: 27568062.
      Citations:    Fields:    Translation:Humans
    168. Lolli C, Basso U, Derosa L, Scarpi E, Sava T, Santoni M, Crabb SJ, Massari F, Aieta M, Conteduca V, Maruzzo M, La Russa F, Wheater M, Berardi R, Galli L, De Giorgi U. Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib. Oncotarget. 2016 08 23; 7(34):54564-54571. PMID: 27409344.
      Citations: 60     Fields:    Translation:Humans
    169. Modena A, Massari F, Ciccarese C, Brunelli M, Santoni M, Montironi R, Martignoni G, Tortora G. Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? Target Oncol. 2016 08; 11(4):431-46. PMID: 26846650.
      Citations: 1     Fields:    Translation:Humans
    170. Schepisi G, Santoni M, Massari F, Gurioli G, Salvi S, Conteduca V, Montironi R, De Giorgi U. Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy. BioDrugs. 2016 Aug; 30(4):263-73. PMID: 27177757.
      Citations: 12     Fields:    Translation:HumansCells
    171. Ciccarese C, Brunelli M, Montironi R, Fiorentino M, Iacovelli R, Heng D, Tortora G, Massari F. The prospect of precision therapy for renal cell carcinoma. Cancer Treat Rev. 2016 Sep; 49:37-44. PMID: 27453294.
      Citations: 24     Fields:    Translation:HumansCells
    172. Mazzucchelli R, Gasparrini S, Galosi AB, Massari F, Raspollini MR, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R. Genitourinary cancers: molecular determinants for personalized therapies. Urologia. 2016 Sep 26; 83(3):107-109. PMID: 27338983.
      Citations:    Fields:    Translation:Humans
    173. Buti S, Ciccarese C, Iacovelli R, Bersanelli M, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R, Tortora G, Massari F. Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 2 - prostate and bladder cancer. Future Oncol. 2016 Sep; 12(17):1971-4. PMID: 27312584.
      Citations:    Fields:    Translation:Humans
    174. Buti S, Ciccarese C, Iacovelli R, Bersanelli M, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R, Tortora G, Massari F. Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 1 - kidney cancer. Future Oncol. 2016 Sep; 12(17):1967-70. PMID: 27312426.
      Citations:    Fields:    Translation:Humans
    175. Kühn AL, Wakhloo AK, Lozano JD, Massari F, De Macedo Rodrigues K, Marosfoi MG, Perras M, Brooks C, Howk M, Rex DE, Gounis MJ, Puri AS. Two-year single-center experience with the 'Baby Trevo' stent retriever for mechanical thrombectomy in acute ischemic stroke. J Neurointerv Surg. 2017 Jun; 9(6):541-546. PMID: 27286991.
      Citations: 3     Fields:    Translation:Humans
    176. Santini D, Santoni M, Conti A, Procopio G, Verzoni E, Galli L, di Lorenzo G, De Giorgi U, De Lisi D, Nicodemo M, Maruzzo M, Massari F, Buti S, Altobelli E, Biasco E, Ricotta R, Porta C, Vincenzi B, Papalia R, Marchetti P, Burattini L, Berardi R, Muto G, Montironi R, Cascinu S, Tonini G. Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma. Oncotarget. 2016 May 31; 7(22):33381-90. PMID: 27027342.
      Citations: 3     Fields:    Translation:Humans
    177. Lozano JD, Massari F, Howk MC, de Macedo Rodrigues K, Brooks C, Perras M, Rex DE, Wakhloo AK, Kühn AL, Puri AS. Utilization of a New Intracranial Support Catheter as an Intermediate Aspiration Catheter in the Treatment of Acute Ischemic Stroke: Technical Report on Initial Experience. Cureus. 2016 May 21; 8(5):e617. PMID: 27382525.
      Citations:    
    178. Mazzucchelli R, Gasparrini S, Galosi AB, Massari F, Ciccarese C, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R. Immunotargeting and personalized therapies in genitourinary cancers. Future Oncol. 2016 Aug; 12(16):1853-6. PMID: 27113700.
      Citations: 1     Fields:    Translation:Humans
    179. Modena A, Ciccarese C, Iacovelli R, Brunelli M, Montironi R, Fiorentino M, Tortora G, Massari F. Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier? Oncol Rev. 2016 Apr 15; 10(1):293. PMID: 27471580.
      Citations:    
    180. Minardi D, Mazzucchelli R, Scarpelli M, Massari F, Ciccarese C, Lopez-Beltran A, Cheng L, Montironi R. Prostate cancer glands with cribriform architecture and with glomeruloid features should be considered as Gleason pattern 4 and not pattern 3. Future Oncol. 2016 Jun; 12(12):1431-3. PMID: 27189718.
      Citations: 2     Fields:    Translation:Humans
    181. Massari F, Ciccarese C, Santoni M, Iacovelli R, Mazzucchelli R, Piva F, Scarpelli M, Berardi R, Tortora G, Lopez-Beltran A, Cheng L, Montironi R. Metabolic phenotype of bladder cancer. Cancer Treat Rev. 2016 Apr; 45:46-57. PMID: 26975021.
      Citations: 81     Fields:    Translation:HumansCells
    182. Massari F, Henninger N, Lozano JD, Patel A, Kuhn AL, Howk M, Perras M, Brooks C, Gounis MJ, Kan P, Wakhloo AK, Puri AS. ARTS (Aspiration-Retriever Technique for Stroke): Initial clinical experience. Interv Neuroradiol. 2016 Jun; 22(3):325-32. PMID: 26908591.
      Citations: 42     Fields:    Translation:Humans
    183. Ciccarese C, Santoni M, Massari F. Chemohormonal Therapy in Hormone-Sensitive Prostate Cancer. N Engl J Med. 2016 01 21; 374(3):286. PMID: 26789884.
      Citations: 1     Fields:    Translation:Humans
    184. Massari F, Ciccarese C, Vau N, Santoni M, Montironi R, Cheng L, Marques RC, Scarpelli M, Fonseca J, Matrana MR, Holger M, Cascinu S, Tortora G, Lopez-Beltran A. Emerging Immunotargets in Bladder Cancer. Curr Drug Targets. 2016; 17(7):757-70. PMID: 26844572.
      Citations: 2     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    185. Montironi R, Santoni M, Massari F, Lopez-Beltran A, Cheng L, Berardi R, Scarpelli M. Editorial: Emerging Immunotargets in Genitourinary Tumors. Curr Drug Targets. 2016; 17(7):748-9. PMID: 27086839.
      Citations: 2     Fields:    Translation:Humans
    186. Montironi R, Santoni M, Sotte V, Cheng L, Lopez-Beltran A, Massari F, Matrana MR, Moch H, Berardi R, Scarpelli M. Emerging Immunotargets and Immunotherapies in Prostate Cancer. Curr Drug Targets. 2016; 17(7):777-82. PMID: 26898309.
      Citations: 4     Fields:    Translation:HumansCells
    187. Kucharczyk J, Matrana MR, Santoni M, Massari F, Scarpelli M, Cheng L, Lopez-Beltran A, Cascinu S, Montironi R, Holger M. Emerging Immunotargets in Metastatic Renal Cell Carcinoma. Curr Drug Targets. 2016; 17(7):771-6. PMID: 26648075.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    188. Montironi R, Santoni M, Cheng L, Lopez-Beltran A, Massari F, Matrana MR, Moch H, Scarpelli M. An Overview of Emerging Immunotargets of Genitourinary Tumors. Curr Drug Targets. 2016; 17(7):750-6. PMID: 26648079.
      Citations: 5     Fields:    Translation:HumansCells
    189. Ciccarese C, Santoni M, Massari F, Modena A, Piva F, Conti A, Mazzucchelli R, Cheng L, Lopez-Beltran A, Scarpelli M, Tortora G, Montironi R. Metabolic Alterations in Renal and Prostate Cancer. Curr Drug Metab. 2016; 17(2):150-5. PMID: 26467063.
      Citations: 9     Fields:    Translation:HumansCells
    190. Puri AS, Massari F, Asai T, Marosfoi M, Kan P, Hou SY, Howk M, Perras M, Brooks C, Clarencon F, Gounis MJ, Wakhloo AK. Safety, efficacy, and short-term follow-up of the use of Pipeline Embolization Device in small (<2.5 mm) cerebral vessels for aneurysm treatment: single institution experience. Neuroradiology. 2016 Mar; 58(3):267-75. PMID: 26700827.
      Citations: 21     Fields:    Translation:Humans
    191. Ciccarese C, Santoni M, Brunelli M, Buti S, Modena A, Nabissi M, Artibani W, Martignoni G, Montironi R, Tortora G, Massari F. AR-V7 and prostate cancer: The watershed for treatment selection? Cancer Treat Rev. 2016 Feb; 43:27-35. PMID: 26827690.
      Citations: 27     Fields:    Translation:HumansCells
    192. Santoni M, Piva F, Scarpelli M, Cheng L, Lopez-Beltran A, Massari F, Iacovelli R, Berardi R, Santini D, Montironi R. The origin of prostate metastases: emerging insights. Cancer Metastasis Rev. 2015 Dec; 34(4):765-73. PMID: 26363603.
      Citations: 14     Fields:    Translation:HumansCells
    193. Massari F, Ciccarese C, Santoni M, Lopez-Beltran A, Scarpelli M, Montironi R, Cheng L. Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma. Expert Rev Anticancer Ther. 2015; 15(12):1367-9. PMID: 26568023.
      Citations: 10     Fields:    Translation:Humans
    194. Kühn AL, Kan P, Massari F, Lozano JD, Hou SY, Howk M, Gounis MJ, Wakhloo AK, Puri AS. Endovascular reconstruction of unruptured intradural vertebral artery dissecting aneurysms with the Pipeline embolization device. J Neurointerv Surg. 2016 Oct; 8(10):1048-51. PMID: 26546600.
      Citations: 13     Fields:    Translation:Humans
    195. Santoni M, Conti A, Piva F, Massari F, Ciccarese C, Burattini L, Cheng L, Lopez-Beltran A, Scarpelli M, Santini D, Tortora G, Cascinu S, Montironi R. Role of STAT3 pathway in genitourinary tumors. Future Sci OA. 2015 Nov; 1(3):FSO15. PMID: 28031890.
      Citations:    
    196. Piva F, Giulietti M, Occhipinti G, Santoni M, Massari F, Sotte V, Iacovelli R, Burattini L, Santini D, Montironi R, Cascinu S, Principato G. Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in renal cell carcinoma. Oncotarget. 2015 Oct 13; 6(31):32161-8. PMID: 26452128.
      Citations: 15     Fields:    Translation:Humans
    197. Conteduca V, Caffo O, Fratino L, Lo Re G, Basso U, D'Angelo A, Donini M, Verderame F, Ratta R, Procopio G, Campadelli E, Massari F, Gasparro D, Ermacora P, Messina C, Giordano M, Alesini D, Zagonel V, Veccia A, Lolli C, Maines F, De Giorgi U. Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients. Future Oncol. 2015; 11(21):2881-91. PMID: 26436290.
      Citations: 5     Fields:    Translation:Humans
    198. Piva F, Santoni M, Matrana MR, Satti S, Giulietti M, Occhipinti G, Massari F, Cheng L, Lopez-Beltran A, Scarpelli M, Principato G, Cascinu S, Montironi R. BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies. Expert Rev Mol Diagn. 2015; 15(9):1201-10. PMID: 26166446.
      Citations: 35     Fields:    Translation:HumansAnimals
    199. Massari F, Ciccarese C, Santoni M, Brunelli M, Piva F, Modena A, Bimbatti D, Fantinel E, Santini D, Cheng L, Cascinu S, Montironi R, Tortora G. Metabolic alterations in renal cell carcinoma. Cancer Treat Rev. 2015 Nov; 41(9):767-76. PMID: 26169313.
      Citations: 36     Fields:    Translation:HumansAnimals
    200. Massari F, Santoni M, Ciccarese C, Santini D. The immunocheckpoints in modern oncology: the next 15 years. Expert Opin Biol Ther. 2015 Jul; 15(7):917-21. PMID: 26063384.
      Citations: 9     Fields:    Translation:Humans
    201. Iacovelli R, Santini D, Rizzo M, Felici A, Santoni M, Verzoni E, Masini C, Massari F, Calvani N, Mosca A, Procopio G. Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinoma. Can Urol Assoc J. 2015 Jul-Aug; 9(7-8):263-7. PMID: 26316911.
      Citations:    
    202. Santoni M, Conti A, Andrikou K, Bittoni A, Lanese A, Pistelli M, Pantano F, Vincenzi B, Armento G, Massari F, Tonini G, Cascinu S, Santini D. Risk of pruritus in cancer patients treated with biological therapies: A systematic review and meta-analysis of clinical trials. Crit Rev Oncol Hematol. 2015 Nov; 96(2):206-19. PMID: 26070625.
      Citations: 9     Fields:    Translation:Humans
    203. Massari F, Bria E, Ciccarese C, Munari E, Modena A, Zambonin V, Sperduti I, Artibani W, Cheng L, Martignoni G, Tortora G, Brunelli M. Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder. PLoS One. 2015; 10(6):e0127908. PMID: 26046361.
      Citations: 15     Fields:    Translation:Humans
    204. Massari F, Santoni M, Ciccarese C, Brunelli M, Conti A, Santini D, Montironi R, Cascinu S, Tortora G. Emerging concepts on drug resistance in bladder cancer: Implications for future strategies. Crit Rev Oncol Hematol. 2015 Oct; 96(1):81-90. PMID: 26022449.
      Citations: 33     Fields:    Translation:Humans
    205. Ciccarese C, Massari F, Santoni M, Heng DY, Sotte V, Brunelli M, Conti A, Cheng L, Lopez-Beltran A, Scarpelli M, Cascinu S, Tortora G, Montironi R. New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials. Cancer Treat Rev. 2015 Jul; 41(7):614-22. PMID: 26036356.
      Citations: 9     Fields:    Translation:HumansCells
    206. Puri AS, Gounis MJ, Massari F, Howk M, Weaver J, Wakhloo AK. Monotherapy with stenting in subarachnoid hemorrhage (SAH) after middle cerebral artery dissection. J Neurointerv Surg. 2016 Apr; 8(4):e13. PMID: 25854687.
      Citations: 1     Fields:    Translation:Humans
    207. Puri AS, Massari F, Hou SY, Lozano JD, Howk M, Perras M, Brooks C, Gounis MJ, Kan P, Wakhloo AK. Onyx embolization in distal dissecting posterior inferior cerebellar artery aneurysms. J Neurointerv Surg. 2016 May; 8(5):501-6. PMID: 25838199.
      Citations: 3     Fields:    Translation:Humans
    208. Puri AS, Gounis MJ, Massari F, Howk M, Weaver J, Wakhloo AK. Monotherapy with stenting in subarachnoid hemorrhage (SAH) after middle cerebral artery dissection. BMJ Case Rep. 2015 Apr 01; 2015. PMID: 25833904.
      Citations:    Fields:    Translation:Humans
    209. Santoni M, Massari F, Del Re M, Ciccarese C, Piva F, Principato G, Montironi R, Santini D, Danesi R, Tortora G, Cascinu S. Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer. Expert Opin Investig Drugs. 2015 Jun; 24(6):809-24. PMID: 25746129.
      Citations: 22     Fields:    Translation:HumansAnimals
    210. Santoni M, Conti A, Procopio G, Porta C, Ibrahim T, Barni S, Guida FM, Fontana A, Berruti A, Berardi R, Massari F, Vincenzi B, Ortega C, Ottaviani D, Carteni G, Lanzetta G, De Lisi D, Silvestris N, Satolli MA, Collovà E, Russo A, Badalamenti G, Luzi Fedeli S, Tanca FM, Adamo V, Maiello E, Sabbatini R, Felici A, Cinieri S, Montironi R, Bracarda S, Tonini G, Cascinu S, Santini D. Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis? J Exp Clin Cancer Res. 2015 Feb 05; 34:10. PMID: 25651794.
      Citations: 39     Fields:    Translation:Humans
    211. Massari F, Ciccarese C, Santoni M, Brunelli M, Conti A, Modena A, Montironi R, Santini D, Cheng L, Martignoni G, Cascinu S, Tortora G. The route to personalized medicine in bladder cancer: where do we stand? Target Oncol. 2015 Sep; 10(3):325-36. PMID: 25634607.
      Citations: 8     Fields:    Translation:HumansCells
    212. Santoni M, Buti S, Conti A, Porta C, Procopio G, Sternberg CN, Bracarda S, Basso U, De Giorgi U, Rizzo M, Derosa L, Ortega C, Massari F, Milella M, Bersanelli M, Cerbone L, Muzzonigro G, Burattini L, Montironi R, Santini D, Cascinu S. Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy. Target Oncol. 2015 Dec; 10(4):517-22. PMID: 25559290.
      Citations: 18     Fields:    Translation:Humans
    213. Lopez-Beltran A, Santoni M, Massari F, Ciccarese C, Tortora G, Cheng L, Moch H, Scarpelli M, Reymundo C, Montironi R. Bladder cancer: molecular determinants of personalized therapy. Curr Drug Targets. 2015; 16(2):115-24. PMID: 25654736.
      Citations: 4     Fields:    Translation:Humans
    214. Santoni M, Massari F, Iacovelli R, Ciccarese C, Verri E, Burattini L, Montironi R, Nolè F, Tortora G, Cascinu S. Inside the 2015 ASCO Genitourinary Cancers Symposium. Future Oncol. 2015; 11(13):1859-62. PMID: 26161923.
      Citations:    Fields:    Translation:Humans
    215. Ciccarese C, Santoni M, Massari F, Cheng L, Lopez-Beltran A, Scarpelli M, Conti A, Tortora G, Cascinu S, Montironi R. Present and future of personalized medicine in adult genitourinary tumors. Future Oncol. 2015; 11(9):1381-8. PMID: 25952784.
      Citations: 5     Fields:    Translation:Humans
    216. Buti S, Ciccarese C, Zanoni D, Santoni M, Modena A, Maines F, Gilli A, Bria E, Brunelli M, Rimanti A, Cascinu S, Ardizzoni A, Tortora G, Massari F. Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand? Future Oncol. 2015; 11(1):107-19. PMID: 25572786.
      Citations: 8     Fields:    Translation:Humans
    217. Santoni M, Conti A, Partelli S, Porta C, Sternberg CN, Procopio G, Bracarda S, Basso U, De Giorgi U, Derosa L, Rizzo M, Ortega C, Massari F, Iacovelli R, Milella M, Di Lorenzo G, Buti S, Cerbone L, Burattini L, Montironi R, Santini D, Falconi M, Cascinu S. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors. Ann Surg Oncol. 2015; 22(6):2094-100. PMID: 25472645.
      Citations: 26     Fields:    Translation:Humans
    218. Iacovelli R, Farcomeni A, Sternberg CN, Cartenì G, Milella M, Santoni M, Cerbone L, Di Lorenzo G, Verzoni E, Ortega C, Sabbatini R, Ricotta R, Messina C, Lorusso V, Atzori F, De Vincenzo F, Sacco C, Boccardo F, Valduga F, Massari F, Baldazzi V, Cinieri S, Mosca A, Maria Ruggeri E, Berruti A, Procopio G. Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma. J Urol. 2015 Jun; 193(6):1905-10. PMID: 25433306.
      Citations: 3     Fields:    Translation:Humans
    219. Bianconi M, Santoni M, Massari F, Faloppi L, Del Prete M, Giampieri R, Ciccarese C, Modena A, Tortora G, Scartozzi M, Cascinu S. Selected news from the 2014 Genitourinary Cancers Symposium: translating novel strategies into clinical practice. Future Oncol. 2014 Nov; 10(14):2103-6. PMID: 25471023.
      Citations:    Fields:    Translation:HumansAnimals
    220. Cianfoni A, Massari F, Ewing S, Persenaire M, Rumboldt Z, Bonaldi G. Combining percutaneous pedicular and extrapedicular access for tumor ablation in a thoracic vertebral body. Interv Neuroradiol. 2014 Oct 31; 20(5):603-8. PMID: 25363263.
      Citations: 2     Fields:    Translation:Humans
    221. Caffo O, De Giorgi U, Fratino L, Lo Re G, Basso U, D'Angelo A, Donini M, Verderame F, Ratta R, Procopio G, Campadelli E, Massari F, Gasparro D, Macrini S, Messina C, Giordano M, Alesini D, Zustovich F, Fraccon AP, Vicario G, Conteduca V, Maines F, Galligioni E. Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme. BJU Int. 2015 May; 115(5):764-71. PMID: 24988879.
      Citations: 4     Fields:    Translation:Humans
    222. Massari F, Ciccarese C, Porcaro AB, Ferrero S, Gazzano G, Artibani W, Modena A, Bria E, Sava T, Caliò A, Novara G, Ficarra V, Chilosi M, Martignoni G, Bosari S, Cheng L, Tortora G, Brunelli M. Quantitative score modulation of HSP90 and HSP27 in clear cell renal cell carcinoma. Pathology. 2014 Oct; 46(6):523-6. PMID: 25188333.
      Citations: 2     Fields:    Translation:Humans
    223. Santoni M, Conti A, Porta C, Procopio G, Sternberg CN, Basso U, De Giorgi U, Bracarda S, Rizzo M, Ortega C, Massari F, Iacovelli R, Derosa L, Masini C, Milella M, Di Lorenzo G, Atzori F, Pagano M, Buti S, De Vivo R, Mosca A, Rossi M, Paglino C, Verzoni E, Cerbone L, Muzzonigro G, Falconi M, Montironi R, Burattini L, Santini D, Cascinu S. Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma. J Urol. 2015 Jan; 193(1):41-7. PMID: 25046616.
      Citations: 23     Fields:    Translation:Humans
    224. Santoni M, Massari F, Cascinu S. Prophylactic use of mTOR inhibitors and other immunosuppressive agents in heart transplant patients. Cell Mol Immunol. 2015 Jan; 12(1):122-4. PMID: 24882385.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    225. Santoni M, Bracarda S, Nabissi M, Massari F, Conti A, Bria E, Tortora G, Santoni G, Cascinu S. CXC and CC chemokines as angiogenic modulators in nonhaematological tumors. Biomed Res Int. 2014; 2014:768758. PMID: 24971349.
      Citations: 30     Fields:    Translation:HumansAnimals
    226. Santoni M, Santini D, Massari F, Conti A, Iacovelli R, Burattini L, Tortora G, Falconi M, Montironi R, Cascinu S. Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside. Cancer Metastasis Rev. 2014 Mar; 33(1):321-31. PMID: 24337954.
      Citations: 8     Fields:    Translation:Humans
    227. Santoni M, Conti A, Massari F, Arnaldi G, Iacovelli R, Rizzo M, De Giorgi U, Trementino L, Procopio G, Tortora G, Cascinu S. Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trials. Int J Cancer. 2015 Jan 01; 136(1):1-10. PMID: 24415642.
      Citations: 18     Fields:    Translation:Humans
    228. Santoni M, Massari F, Amantini C, Nabissi M, Maines F, Burattini L, Berardi R, Santoni G, Montironi R, Tortora G, Cascinu S. Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma. Cancer Immunol Immunother. 2013 Dec; 62(12):1757-68. PMID: 24132754.
      Citations: 56     Fields:    Translation:HumansAnimalsCells
    229. Iacovelli R, Cartenì G, Sternberg CN, Milella M, Santoni M, Di Lorenzo G, Ortega C, Sabbatini R, Ricotta R, Messina C, Lorusso V, Atzori F, De Vincenzo F, Sacco C, Boccardo F, Valduga F, Massari F, Baldazzi V, Cinieri S, Mosca A, Ruggeri EM, Berruti A, Cerbone L, Procopio G. Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: results from a large patient cohort. Eur J Cancer. 2013 Jun; 49(9):2134-42. PMID: 23518211.
      Citations: 23     Fields:    Translation:Humans
    230. Gandini R, Chiaravalloti A, Pampana E, Massari F, Morosetti D, Spano S, Loreni G, Simonetti G. Intracranial atheromatous disease treatment with the Wingspan stent system: evaluation of clinical, procedural outcome and restenosis rate in a single-center series of 21 consecutive patients with acute and mid-term results. Clin Neurol Neurosurg. 2013 Jun; 115(6):741-7. PMID: 22989778.
      Citations: 7     Fields:    Translation:Humans
    231. Speziale G, Nasso G, Piancone F, Generali K, Paterno C, Miccoli A, Fiore F, Del Prete A, Del Prete G, Lopriore V, Spirito F, Caldarola P, Paparella D, Massari F, Tavazzi L. One-year results after implantation of the CorCap for dilated cardiomyopathy and heart failure. Ann Thorac Surg. 2011 May; 91(5):1356-62. PMID: 21524444.
      Citations: 3     Fields:    Translation:Humans
    232. Masala S, Mammucari M, Angelopoulos G, Fiori R, Massari F, Faria S, Simonetti G. Percutaneous vertebroplasty in the management of vertebral osteoporotic fractures. Short-term, mid-term and long-term follow-up of 285 patients. Skeletal Radiol. 2009 Sep; 38(9):863-9. PMID: 19434408.
      Citations: 4     Fields:    Translation:Humans
    233. Masala S, Mastrangeli R, Petrella MC, Massari F, Ursone A, Simonetti G. Percutaneous vertebroplasty in 1,253 levels: results and long-term effectiveness in a single centre. Eur Radiol. 2009 Jan; 19(1):165-71. PMID: 18704433.
      Citations: 22     Fields:    Translation:Humans
    234. Masala S, Anselmetti GC, Marcia S, Massari F, Manca A, Simonetti G. Percutaneous vertebroplasty in multiple myeloma vertebral involvement. J Spinal Disord Tech. 2008 Jul; 21(5):344-8. PMID: 18600145.
      Citations: 15     Fields:    Translation:Humans
    235. Masala S, Pipitone V, Tomassini M, Massari F, Romagnoli A, Simonetti G. Percutaneous vertebroplasty in painful schmorl nodes. Cardiovasc Intervent Radiol. 2006 Jan-Feb; 29(1):97-101. PMID: 16328689.
      Citations: 14     Fields:    Translation:Humans
    236. Masala S, Schillaci O, Massari F, Danieli R, Ursone A, Fiori R, Simonetti G. MRI and bone scan imaging in the preoperative evaluation of painful vertebral fractures treated with vertebroplasty and kyphoplasty. In Vivo. 2005 Nov-Dec; 19(6):1055-60. PMID: 16277022.
      Citations: 9     Fields:    Translation:Humans
    237. Masala S, Fiori R, Massari F, Simonetti G. Kyphoplasty: indications, contraindications and technique. Radiol Med. 2005 Jul-Aug; 110(1-2):97-105. PMID: 16163144.
      Citations: 7     Fields:    Translation:Humans
    238. Pitzalis MV, Iacoviello M, Romito R, Massari F, Rizzon B, Luzzi G, Guida P, Andriani A, Mastropasqua F, Rizzon P. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol. 2002 Nov 06; 40(9):1615-22. PMID: 12427414.
      Citations: 135     Fields:    Translation:HumansCTClinical Trials
    Massari's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (443)
    Explore
    _
    Co-Authors (11)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _